Ron J. Keizer

Clinical Pharmacokinetics · 2010–2013

A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Whom Ron J. Keizer trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Florian Maria Wurm
  2. P. Carter
  3. Lars Lindbom

Papers from Ron J. Keizer's perspective

Ordered by how strongly the researchers Ron J. Keizer trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Potent antibody therapeutics by design (Nature reviews. Immunology)
  2. Antibody pharmacokinetics and pharmacodynamics. (Journal of Pharmacy and Science)
  3. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. (New England Journal of Medicine)
  4. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. (New England Journal of Medicine)
  5. Comparing antibody and small-molecule therapies for cancer (Nature Reviews. Cancer)
  6. Production of recombinant protein therapeutics in cultivated mammalian cells (Nature Biotechnology)
  7. The Hypercycle: A principle of natural self-organization
  8. Monoclonal antibody successes in the clinic (Nature Biotechnology)
  9. Engineered antibody Fc variants with enhanced effector function.
  10. Perl-speaks-NONMEM (PsN) - a Perl module for NONMEM related programming (Comput. Methods Programs Biomed.)

Their papers